Peculiarities of Clinical Symptoms, Somatic Complications, Approaches to Therapy and Outcomes of Delirium Induced by Exposure to Synthetic Cannabinoids: Systematic Review
- 12 October 2023
- journal article
- review article
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 31 (3) , 467-479
Abstract
INTRODUCTION: The use of synthetic cannabinoids (SCs) is an urgent healthcare problem, due to, among other things, a high number of complications. AIM: To systematize the peculiarities of clinical presentation, somatic complications, effectiveness of empirical approaches to therapy, and probable outcomes of delirium induced by exposure to SCs. MATERIALS AND METHODS: The analysis of scientific publications selected by the keywords in eLibrary, СNKI, PubMed databases, was conducted. According to PRISMA recommendations, 20 articles were taken for analysis. RESULTS: Today, it is impossible to predict the period when SC-induced delirium may occur. It can start after one-time intake of even small dose, and can occur both due to intoxication and with the underlying withdrawal state on the 2nd4th days after the last use. Besides classic symptoms, the clinical picture of delirium is characterized by many symptoms of schizophrenic psychoses: hallucinations of threatening or drug-addicted content; secondary paranoid delusion, less expressed than hallucinations; aggressiveness and agitated behavior; some formal thinking disorders; rarely, KandinskiClerambault and oneiroid syndromes. There are reported cases of severe somatic complications in the form of depression of consciousness, rhabdomyolysis, acute renal failure, cardiomyopathy, myocardial infarction, epilepsy, infectious complications with the underlying weakened immunity. Therapy of SC-induced delirium includes detoxification and metabolic therapy, administration of antipsychotics and tranquilizers; use of resuscitation measures in case of depression of consciousness and development of life-threatening conditions. SC-induced delirium lasts from several hours to several days. In most cases, it terminates with complete recovery with amnesia of the period of confusion and asthenia, but in some cases fatal outcomes are reported caused not only by accidents such as road accidents or suicide, but also by somatic complications (most often of infectious character, or multi-organ failure). CONCLUSION: SСs remain relevant due to high frequency of their use and continuous emergence of new analogs to substances of this group. They have multidirectional effect, and so far it is difficult to predict at what period the delirium induced by them may occur.Keywords
This publication has 15 references indexed in Scilit:
- Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literatureNeuropharmacology, 2018
- Лечение острого психоза вследствие употребления синтетических каннабиноидовСибирский вестник психиатрии и наркологии, 2017
- PSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук, 2017
- Synthetic cannabinoid “Black Mamba” infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN CohortClinical Toxicology, 2017
- Delirium and High Creatine Kinase and Myoglobin Levels Related to Synthetic Cannabinoid WithdrawalCase Reports in Medicine, 2017
- Synthetic cannabinoid drug use as a cause or contributory cause of deathForensic Science International, 2016
- Hyperthermia and severe rhabdomyolysis from synthetic cannabinoidsThe American Journal of Emergency Medicine, 2016
- An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACAClinical Toxicology, 2015
- Synthetic Cannabinoid ‘Bonzai’ Intoxication: Six Case SeriesTurkish Journal of Anesthesia and Reanimation, 2015
- A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACAThe Journal of Emergency Medicine, 2015